Product
AT-GTX-502
1 clinical trial
2 indications
Indication
CLN3Indication
Batten DiseaseClinical trial
Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9Status: Active (not recruiting), Estimated PCD: 2024-09-30